SCHEMBL21052504

SCHEMBL21052504

COC(=O)C1CN(C(=O)O)CCN1c1c([N+](=O)[O-])cnc2cc(Br)c(Cl)cc12

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
CYP8B1 Q9UNU6 1/20 0.35
PDGFRB P09619 4/20 0.35
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DYRK1B Q9Y463 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PIK3CD O00329 2/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
KRAS P01116 1/20 0.32
EGFR P00533 2/20 0.31
ERBB2 P04626 1/20 0.31
HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21050673 0.90 ABL1 (0.38) ABL1BCRCYP8B1PDGFRBMAPT
SCHEMBL21050822 0.89 MET (0.39) CYP8B1PDGFRBMAPTALDH1A1PIK3CD
SCHEMBL21100021 0.89 MET (0.39) CYP8B1PDGFRBMAPTALDH1A1PIK3CD
SCHEMBL21050676 0.84 ABL1 (0.36) ABL1BCRCYP8B1PDGFRBALDH1A1
SCHEMBL21050677 0.84 ABL1 (0.36) ABL1BCRCYP8B1PDGFRBALDH1A1
SCHEMBL21050918 0.84 ABL1 (0.36) ABL1BCRCYP8B1PDGFRBALDH1A1
SCHEMBL21050764 0.84 ABL1 (0.36) ABL1BCRCYP8B1PDGFRBALDH1A1
SCHEMBL21050944 0.80 ABL1 (0.36) ABL1BCRCYP8B1PDGFRBALDH1A1
SCHEMBL21099318 0.77 MET (0.39) MAPTALDH1A1PIK3CD
SCHEMBL21050820 0.76 MAPT (0.37) ABL1BCRMAPTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed